Evidence map›Paper›PMID 33293427›Full record

ArticleCancer research2021

A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.

Nima C Emami, Taylor B Cavazos, Sara R Rashkin, Clinton L Cario, Rebecca E Graff, Caroline G Tai, Joel A Mefford, Linda Kachuri, Eunice Wan, Simon Wong and 16 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 2 countries.

Nima C Emami *Program in Biological and Medical Informatics, University of California San Francisco, San Francisco, California.ORCID 0000-0002-4296-7805
Taylor B Cavazos *Program in Biological and Medical Informatics, University of California San Francisco, San Francisco, California.ORCID 0000-0003-3537-2608
Sara R RashkinDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.ORCID 0000-0001-5542-6891
Clinton L CarioProgram in Biological and Medical Informatics, University of California San Francisco, San Francisco, California.
Rebecca E GraffDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.ORCID 0000-0003-0316-8303
Caroline G TaiDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.ORCID 0000-0001-5041-5114
Joel A MeffordProgram in Pharmaceutical Sciences and Pharmacogenomics, University of California San Francisco, San Francisco, California.
Linda KachuriDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.ORCID 0000-0002-3226-4727
Eunice WanInstitute for Human Genetics, University of California San Francisco, San Francisco, California.
Simon WongInstitute for Human Genetics, University of California San Francisco, San Francisco, California.
David AaronsonDepartment of Urology, Kaiser Oakland Medical Center, Oakland, California.
Joseph PrestiDepartment of Urology, Kaiser Oakland Medical Center, Oakland, California.
Laurel A HabelDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Jun ShanDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Dilrini K RanatungaDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Chun R ChaoDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Nirupa R GhaiDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Eric JorgensonDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Lori C SakodaDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0002-0900-5735
Mark N KvaleInstitute for Human Genetics, University of California San Francisco, San Francisco, California.
Pui-Yan KwokProgram in Pharmaceutical Sciences and Pharmacogenomics, University of California San Francisco, San Francisco, California.
Catherine SchaeferDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Neil RischProgram in Biological and Medical Informatics, University of California San Francisco, San Francisco, California.
Thomas J HoffmannProgram in Biological and Medical Informatics, University of California San Francisco, San Francisco, California.
Stephen K Van Den EedenDivision of Research, Kaiser Permanente Northern California, Oakland, California.ORCID 0000-0002-5599-8387
John S WitteProgram in Biological and Medical Informatics, University of California San Francisco, San Francisco, California. jwitte@ucsf.edu.
University of California, San Francisco · USKaiser Permanente · USKaiser Permanente Oakland Medical Center · USUniversity of California San Francisco Medical Center · US

Funding

A Resource for Genetic Epidemiology Research in Adult Health and AgingRC2AG036607 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI RISCH, NEIL J., SCHAEFER, CATHERINE ANN · 2009 to 2010
$24.8M
BMI Bioinformatics Training GrantsT32GM067547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HERNANDEZ, RYAN D. · 2003 to 2022
$6.6M
Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
Genetic Epidemiology of Prostate Cancer Risk and ProgressionR01CA088164 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAN DEN EEDEN, STEPHEN K., WITTE, JOHN S. · 2000 to 2015
$6.1M
Genomewide Association Study of Prostate CancerU01CA127298 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2008 to 2012
$5.1M
Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen LevelsR01CA241410 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI John S. Witte · 2020 to 2026
$3.7M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
Genome-wide Pleiotropy Scan across Multiple CancersR01CA201358 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRAFF, REBECCA ELIZABETH, SAKODA, LORI · 2016 to 2019
$2.5M
Training in the Molecular & Genetic Epidemiology of CancerT32CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHENG, IONA C, ZIV, ELAD · 2020 to 2024
$1.8M
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NCI NIH HHS R01 CA088164NCI NIH HHS R01 CA201358NCI NIH HHS R01 CA241410NCI NIH HHS R25 CA112355NCI NIH HHS T32 CA112355NCI NIH HHS U01 CA127298NIA NIH HHS RC2 AG036607NIBIB NIH HHS T32 EB009383NIGMS NIH HHS T32 GM067547
6 · The paper itself

Abstract

To identify rare variants associated with prostate cancer susceptibility and better characterize the mechanisms and cumulative disease risk associated with common risk variants, we conducted an integrated study of prostate cancer genetic etiology in two cohorts using custom genotyping microarrays, large imputation reference panels, and functional annotation approaches. Specifically, 11,984 men (6,196 prostate cancer cases and 5,788 controls) of European ancestry from Northern California Kaiser Permanente were genotyped and meta-analyzed with 196,269 men of European ancestry (7,917 prostate cancer cases and 188,352 controls) from the UK Biobank. Three novel loci, including two rare variants (European ancestry minor allele frequency < 0.01, at 3p21.31 and 8p12), were significant genome wide in a meta-analysis. Gene-based rare variant tests implicated a known prostate cancer gene (

Indexed as

Multifactorial InheritanceProstatic NeoplasmsGenetic Predisposition to DiseaseGenome-Wide Association StudyGenomicsHumansMalePolymorphism, Single Nucleotide

Identifiers

PMID33293427
PMCPMC8137514
OpenAlexW3113298620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.